摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,7-dibromo-4-nitrobenzo[c][1,2,5]oxadiazole | 52120-98-6

中文名称
——
中文别名
——
英文名称
5,7-dibromo-4-nitrobenzo[c][1,2,5]oxadiazole
英文别名
5,7-dibromo-4-nitro-2,1,3-benzoxadiazole;5,7-dibromo-4-nitro-benzo[1,2,5]oxadiazole;4,6-Dibrom-4-nitrobenzofurazan;Benzofurazan, 5,7-dibromo-4-nitro-
5,7-dibromo-4-nitrobenzo[c][1,2,5]oxadiazole化学式
CAS
52120-98-6
化学式
C6HBr2N3O3
mdl
——
分子量
322.9
InChiKey
UCKRCRBZQRANIK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    14
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    84.7
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF HIF2-ALPHA AND THEIR METHODS OF USE<br/>[FR] COMPOSÉS ET COMPOSITIONS PERMETTANT D'INHIBER L'ACTIVITÉ DE HIF2-ALPHA ET LEURS PROCÉDÉS D'UTILISATION
    申请人:NOVARTIS AG
    公开号:WO2021220170A1
    公开(公告)日:2021-11-04
    The present invention relates to compounds of formula (I) or a pharmaceutically acceptable salt form thereof, wherein the substituents are as defined in the specification; to intermediates in the preparation of the compounds, to pharmaceutical compositions comprising the compounds and to the use of the compounds in the treatment of disease. The compounds are inhibitors or modulators of HIF2alpha.
    本发明涉及公式(I)的化合物或其药用可接受的盐形式,其中取代基如规范中所定义;制备该化合物的中间体;包含该化合物的药物组合物;以及利用该化合物治疗疾病。这些化合物是HIF2alpha的抑制剂或调节剂。
  • Agent and method for dyeing keratin fibers
    申请人:——
    公开号:US20030070239A1
    公开(公告)日:2003-04-17
    The present invention relates to a fiber-dyeing agent (A) prepared by mixing two components (A1) and (A2), said agent being characterized in that component (A1) contains at least one compound of formula (I) 1 wherein X denotes a halogen atom, a methoxy group or an ethoxy group; Y denotes an oxygen atom, a sulfur atom or a selenium atom; R1 and R2 are equal or different and independently of each other denote hydrogen, a halogen atom, a (C 1 -C 4 )-alkyl group, a halogen-substituted (C 1 -C 4 )-alkyl group, a (C 1 -C 4 )-alkoxy group, a nitro group, an acetamido group or an NR a R b group, wherein the R a and R b groups are equal or different and independently of each other denote hydrogen, a (C 1 -C 4 )-alkyl group, an optionally substituted aromatic carbon ring or a (C 1 -C 4 )-alkanecarbonyl group, or R a and R b together with the nitrogen atom form a heterocyclic (C 3 -C 6 ) group, and component (A2) contains at least one compound from the group consisting of amines, aminonitrobenzenes and phenols; to a method for dyeing hair by use of said agent, and to a multicomponent kit.
    本发明涉及一种纤维染料剂(A),其由混合两个组分(A1)和(A2)制备而成,其中该剂特征在于组分(A1)包含至少一个式(I)1的化合物,其中X表示卤素原子、甲氧基或乙氧基;Y表示氧原子、硫原子或硒原子;R1和R2相等或不同且独立地表示氢、卤素原子、(C1-C4)烷基、卤素取代的(C1-C4)烷基、(C1-C4)烷氧基、硝基、乙酰胺基或NRaRb基,其中Ra和Rb基相等或不同且独立地表示氢、(C1-C4)烷基、可选取代的芳环碳环或(C1-C4)烷基羰基基团,或Ra和Rb与氮原子一起形成杂环(C3-C6)基团,而组分(A2)包含至少一种来自胺、氨基硝基苯和酚的化合物组成的群体中的化合物;以及一种使用该剂染发的方法和多组分套装。
  • INHIBITION OF HIF-2ALPHA HETERODIMERIZATION WITH HIF1BETA (ARNT)
    申请人:THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    公开号:US20160250216A1
    公开(公告)日:2016-09-01
    Provided is a method of inhibiting heterodimerization of HIF-2α to HIF1β (ARNT) comprising binding certain small molecules to the HIF-2α PAS-B domain cavity but not to HIF1α and inhibiting HIF-2α heterodimerization to HIF1β (ARNT) but not inhibiting HIF1α heterodimerization to HIF1β (ARNT). Those certain small molecules are also referenced synonymously as HIF2-HDI and HIF2α heterodimerization inhibitors and also simply as certain small molecules.
    提供了一种抑制HIF-2α与HIF1β(ARNT)异源二聚化的方法,包括将某些小分子结合到HIF-2α PAS-B结构域的空腔中,但不结合到HIF1α,从而抑制HIF-2α与HIF1β(ARNT)的异源二聚化,但不抑制HIF1α与HIF1β(ARNT)的异源二聚化。这些特定的小分子也被同义地称为HIF2-HDI和HIF2α异源二聚化抑制剂,也被简称为某些小分子。
  • Development of Inhibitors of the PAS-B Domain of the HIF-2α Transcription Factor
    作者:Jamie L. Rogers、Liela Bayeh、Thomas H. Scheuermann、Jamie Longgood、Jason Key、Jacinth Naidoo、Lisa Melito、Cameron Shokri、Doug E. Frantz、Richard K. Bruick、Kevin H. Gardner、John B. MacMillan、Uttam K. Tambar
    DOI:10.1021/jm301847z
    日期:2013.2.28
    Hypoxia inducible factors (HIFs) are heterodimeric transcription factors induced in a variety of pathophysiological settings, including cancer. We describe the first detailed structure-activity relationship study of small molecules designed to inhibit HIF-2 alpha-ARNT heterodimerization by binding an internal cavity of the HIF-2 alpha PAS-B domain. Through a series of biophysical characterizations of inhibitor-protein interactions (NMR and X-ray crystallography), we have established the structural requirements for artificial inhibitors of the HIF-2 alpha-ARNT PAS-B interaction. These results may serve as a foundation for discovering therapeutic agents that function by a novel mode of action.
  • MITTEL UND VERFAHREN ZUM FÄRBEN VON KERATINFASERN
    申请人:Wella Aktiengesellschaft
    公开号:EP1328244B1
    公开(公告)日:2006-10-11
查看更多

同类化合物

重氮二硝基苯酚 达罗地平 苯并芙咱-5-硼酸频那醇酯 苯并氧化呋咱-5-羧酸 苯并呋扎-5-甲腈 苯并呋喃-5-磺酰氯 苯并呋喃-5-甲酸乙酯 苯并呋喃 苯并呋咱-5-羧酸乙酯 苯并呋咱-5-羧酸 苯并呋咱-5-碳酰氯 苯并呋咱 苯并二唑-4-甲醛 苯呋咱-5-三氟硼酸钾 硝基氨基吡咯烷苯并恶嗪 哌嗪酮,6-甲基-5-硫代-,(R)-(9CI) 去甲基伊拉地平 伊拉地平内酯 伊拉地平EP杂质A 伊拉地平 乙酮,1-[5-(丁基氨基)-2-羟基苯基]- NBD-双十六胺 N-[12-[((7-硝基-2-1,3-苯并恶二唑-4-基)氨基]十二烷酰基]-D-赤型-鞘氨醇 N-7-(4-硝基苯并-2-氧代-1,3-二氮唑)-omega-氨基己酸beta-(N-三甲基铵)乙酯 N-(7-硝基苯并-2-氧杂-1,3-二氮唑-4-基)磷脂酰乙醇胺 N-(3-氯-5-氟苯基)-4-硝基-2,1,3-苯并恶二唑-5-胺 N-(2-吗啉基乙基)-7-硝基-2,1,3-苯并恶二唑-4-胺 N,N-二甲基-7-硝基苯并呋咱-4-胺 N,N-二丁基-7-硝基-4-苯并呋咱胺 N'-[5-[[4-[5-(乙酰基-羟基氨基)戊基氨基]-4-氧代丁酰基]-羟基氨基]戊基]-N-羟基-N-[5-[(4-硝基-2,1,3-苯并恶二唑-7-基)氨基]戊基]丁二酰胺 8-异米索前列醇 7-肼-N,N-二-4-苯并呋咱磺 7-硝基-N-[2-(2-吡啶基二硫代)乙基]-2,1,3-苯并恶二唑-4-胺 7-硝基-1-氧代-2,1,3-苯并恶二唑-1-鎓 7-甲氧基-2,1,3-苯并恶二唑-4-磺酰氯 7-氯苯并[c][1,2,5]噁二唑-4-胺 7-氯-N,N-二乙基-4-硝基-2,1,3-苯并恶二唑-5-胺 7-氯-4-硝基-5-哌啶基-2,1,3-苯并噁二唑 7-氯-4-硝基-2,1,3-苯并噁二唑1-氧化 7-氯-2,1,3-苯并噁二唑-4-磺酸 7-氟苯呋咱-4-磺酰胺 7-氟苯呋咱-4-硫氨 7-氟-2,1,3-苯并恶二唑-4-磺酰氯 7-哌啶-1-基-2,1,3-苯并恶二唑-4-胺 7-吗啉-4-基苯并[1,2,5]恶二唑-4-基胺 6-溴苯并[c][1,2,5]噁二唑1-氧化物 6-氟-2,1,3-苯并恶二唑-5-胺 6-[[7-(N,N-二甲氨基磺酰)-2,1,3-苯并恶二唑-4-基]氨基]己酸琥珀酰亚胺酯 6-[(7-硝基-2,1,3-苯并恶二唑-4-基)氨基]己酸 6,7-二氢-1,2,3,10-四甲氧基-7-[甲基(7-硝基-2,1,3-苯并恶二唑-4-基)氨基]-(7S)-苯并[a]庚搭烯-9(5H)-酮